FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092530325> ?p ?o ?g. }

• W2092530325 endingPage "60" @default.
• W2092530325 startingPage "53" @default.
• W2092530325 abstract "Aims We hypothesised that accelerated fractionated radiotherapy may provide a good palliative approach for dysphagia relief in patients with incurable oesophageal cancer, significantly reducing the overall duration of treatment, while providing symptom response with an acceptable toxicity profile. A phase I/II accelerated fractionation study was conducted to evaluate the efficacy and toxicity of this approach. Materials and methods Patients with incurable oesophageal cancer, symptomatic with dysphagia, Eastern Cooperative Oncology Group performance status≤3, without fistula or oesophageal stent in situ, were eligible. Treatment consisted of 40 Gy in 20 fractions, twice a day (2 Gy per fraction, ≥6 h apart), 5 days a week, over 2 weeks. Results Of the 39 evaluable patients, the dysphagia response rate was 69% (27/39) with a median response duration of 5.5 months. The median time to response was 4 weeks. Twenty-eight per cent (11/39) of patients had transient worsening in their dysphagia scores. Acute toxicity (weeks 1–8) occurred in 41% (16/39) of patients. An improvement in global quality of life by week 8 was seen in 42% of patients. There were no late neurological sequelae. The median overall survival was 8 (range 1.7–58+) months. Conclusion The ideal palliative regimen should be relatively short, with minimal toxicity, while offering a favourable response profile. Accelerated fractionation fulfils these criteria and is a suitable treatment alternative for the palliation of dysphagia, especially if the goal is to deliver a higher total biological dose within a shorter (2 week) period of time." @default.
• W2092530325 created "2016-06-24" @default.
• W2092530325 creator A5002216968 @default.
• W2092530325 creator A5003931641 @default.
• W2092530325 creator A5006722930 @default.
• W2092530325 creator A5007257314 @default.
• W2092530325 creator A5007725593 @default.
• W2092530325 creator A5019983489 @default.
• W2092530325 creator A5021732017 @default.
• W2092530325 creator A5028863313 @default.
• W2092530325 creator A5032753703 @default.
• W2092530325 creator A5041840951 @default.
• W2092530325 creator A5059619380 @default.
• W2092530325 creator A5080238562 @default.
• W2092530325 date "2008-02-01" @default.
• W2092530325 modified "2023-10-17" @default.
• W2092530325 title "A Phase I/II Study to Evaluate the Toxicity and Efficacy of Accelerated Fractionation Radiotherapy for the Palliation of Dysphagia from Carcinoma of the Oesophagus" @default.
• W2092530325 cites W1947168884 @default.
• W2092530325 cites W1965628104 @default.
• W2092530325 cites W1970476899 @default.
• W2092530325 cites W1984771701 @default.
• W2092530325 cites W1989996489 @default.
• W2092530325 cites W1995886305 @default.
• W2092530325 cites W2006165841 @default.
• W2092530325 cites W2006639706 @default.
• W2092530325 cites W2011486966 @default.
• W2092530325 cites W2013623805 @default.
• W2092530325 cites W2014435840 @default.
• W2092530325 cites W2028527958 @default.
• W2092530325 cites W2029409133 @default.
• W2092530325 cites W2038024865 @default.
• W2092530325 cites W2039612753 @default.
• W2092530325 cites W2051183254 @default.
• W2092530325 cites W2051356168 @default.
• W2092530325 cites W2056009187 @default.
• W2092530325 cites W2060869183 @default.
• W2092530325 cites W2064079568 @default.
• W2092530325 cites W2068605435 @default.
• W2092530325 cites W2070532701 @default.
• W2092530325 cites W2076381935 @default.
• W2092530325 cites W2080009576 @default.
• W2092530325 cites W2084532999 @default.
• W2092530325 cites W2089205578 @default.
• W2092530325 cites W2094866622 @default.
• W2092530325 cites W2104846344 @default.
• W2092530325 cites W2118946732 @default.
• W2092530325 cites W2119696360 @default.
• W2092530325 cites W2141057598 @default.
• W2092530325 cites W2144026725 @default.
• W2092530325 cites W2144263975 @default.
• W2092530325 cites W2144900619 @default.
• W2092530325 cites W2333908381 @default.
• W2092530325 doi "https://doi.org/10.1016/j.clon.2007.10.003" @default.
• W2092530325 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18345545" @default.
• W2092530325 hasPublicationYear "2008" @default.
• W2092530325 type Work @default.
• W2092530325 sameAs 2092530325 @default.
• W2092530325 citedByCount "32" @default.
• W2092530325 countsByYear W20925303252012 @default.
• W2092530325 countsByYear W20925303252013 @default.
• W2092530325 countsByYear W20925303252015 @default.
• W2092530325 countsByYear W20925303252016 @default.
• W2092530325 countsByYear W20925303252018 @default.
• W2092530325 countsByYear W20925303252019 @default.
• W2092530325 countsByYear W20925303252020 @default.
• W2092530325 countsByYear W20925303252021 @default.
• W2092530325 countsByYear W20925303252022 @default.
• W2092530325 countsByYear W20925303252023 @default.
• W2092530325 crossrefType "journal-article" @default.
• W2092530325 hasAuthorship W2092530325A5002216968 @default.
• W2092530325 hasAuthorship W2092530325A5003931641 @default.
• W2092530325 hasAuthorship W2092530325A5006722930 @default.
• W2092530325 hasAuthorship W2092530325A5007257314 @default.
• W2092530325 hasAuthorship W2092530325A5007725593 @default.
• W2092530325 hasAuthorship W2092530325A5019983489 @default.
• W2092530325 hasAuthorship W2092530325A5021732017 @default.
• W2092530325 hasAuthorship W2092530325A5028863313 @default.
• W2092530325 hasAuthorship W2092530325A5032753703 @default.
• W2092530325 hasAuthorship W2092530325A5041840951 @default.
• W2092530325 hasAuthorship W2092530325A5059619380 @default.
• W2092530325 hasAuthorship W2092530325A5080238562 @default.
• W2092530325 hasConcept C121608353 @default.
• W2092530325 hasConcept C126322002 @default.
• W2092530325 hasConcept C141071460 @default.
• W2092530325 hasConcept C159110408 @default.
• W2092530325 hasConcept C2776907518 @default.
• W2092530325 hasConcept C2780596822 @default.
• W2092530325 hasConcept C2781413609 @default.
• W2092530325 hasConcept C29730261 @default.
• W2092530325 hasConcept C2994186709 @default.
• W2092530325 hasConcept C509974204 @default.
• W2092530325 hasConcept C71924100 @default.
• W2092530325 hasConceptScore W2092530325C121608353 @default.
• W2092530325 hasConceptScore W2092530325C126322002 @default.
• W2092530325 hasConceptScore W2092530325C141071460 @default.
• W2092530325 hasConceptScore W2092530325C159110408 @default.
• W2092530325 hasConceptScore W2092530325C2776907518 @default.
• W2092530325 hasConceptScore W2092530325C2780596822 @default.

• next